Health Care & Life Sciences » Pharmaceuticals | Shanxi Zhendong Pharmaceutical Co. Ltd.

Shanxi Zhendong Pharmaceutical Co. Ltd. | Balance Sheet

Fiscal year is January-December. All values CNY Millions.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
346
239
310
747
824
963
Total Accounts Receivable
589
605
907
1,367
1,982
1,532
Inventories
234
314
414
407
481
573
Other Current Assets
105
113
111
230
152
138
Total Current Assets
1,273
1,272
1,742
2,750
3,440
3,206
Net Property, Plant & Equipment
994
1,038
1,119
1,143
1,127
1,106
Total Investments and Advances
13
12
12
38
36
22
Long-Term Note Receivable
-
1
1
1
5
5
Intangible Assets
486
499
529
2,879
2,887
2,747
Other Assets
10
19
646
30
87
99
Total Assets
2,797
2,858
4,070
6,875
7,613
7,213
ST Debt & Current Portion LT Debt
347
365
868
455
533
Accounts Payable
159
168
245
233
278
Income Tax Payable
17
6
17
41
30
Other Current Liabilities
180
209
740
544
879
Total Current Liabilities
704
748
1,870
1,273
1,719
Long-Term Debt
-
-
60
39
33
Provision for Risks & Charges
32
32
32
32
32
Deferred Taxes
22
18
21
26
27
Other Liabilities
-
25
14
165
167
Total Liabilities
736
804
1,975
1,516
1,956
Common Equity (Total)
1,946
1,959
1,995
5,246
5,541
Total Shareholders' Equity
1,946
1,959
1,995
5,246
5,541
Total Equity
1,958
1,970
2,030
5,272
5,558
Liabilities & Shareholders' Equity
2,797
2,858
4,070
6,875
7,613
Accumulated Minority Interest
12
11
35
26
17
Non-Equity Reserves
103
84
65
87
100

About Shanxi Zhendong Pharmaceutical Co.

View Profile
Address
Zhendong Technology Park
Changzhi Shanxi 047100
China
Employees -
Website http://www.zdjt.com
Updated 07/08/2019
Shanxi Zhendong Pharmaceutical Co., Ltd. engages in the research and development, manufacture, and distribution of Chinese traditional medicines and western medicines. Its main products include Yanshu injection, Norfloxacin, Shuxuening injection, Guanxinning injection, Amoxicillin Sodium for injection, Cefathiamidine for injection, and Riboflavin Sodium Phosphate for injection. The company was founded on November 22, 1993 and is headquartered in Changzhi, China.